文献速递心脑血管急症重症综合管理与镇静镇痛

红细胞分布宽度与血清钙比值联合N末端B型利钠肽前体预测中重度创伤性脑损伤结局的预后模型开发与验证

Development and Validation of a Prognostic Model Integrating the Red Cell Distribution Width-to-Serum Calcium Ratio and N-terminal pro-B-type Natriuretic Peptide for Outcome Prediction after Moderate-to-Severe Traumatic Brain Injury.
PubMed 文献 · Neurocrit Care · 2026-02-19
一句话结论在中重度TBI患者中,RCR和NT-proBNP升高与6个月不良结局独立相关,二者加入IMPACT模型可提高区分度(AUC 0.924 vs 0.874)。

该研究回顾性分析了苏州大学附属第一医院创伤中心与神经外科2023年1月至2025年1月连续收治的210例中重度TBI患者,主要终点为6个月不良结局(Glasgow结局量表评分<4)。多变量logistic回归显示,较高的RCR和NT-proBNP与不良结局独立相关(RCR校正OR 4.871,95%CI 1.929-12.300;ln(NT-proBNP)校正OR 2.495,95%CI 1.648-3.776;均p<0.001)。不良结局率随RCR三分位升高而上升(21.4%、47.9%、63.8%;p<0.001)。将两种生物标志物加入IMPACT模型后区分度改善(AUC 0.924 vs. 0.874;p<0.001)。作者认为联合评估RCR和NT-proBNP可提高中重度TBI的早期预后准确性,支持其作为可及生物标志物用于细化风险分层和个体化管理。

要点

  • 在中重度TBI患者中,RCR较高与6个月不良结局独立相关(校正OR 4.871,95%CI 1.929-12.300,p<0.001)。
  • NT-proBNP较高与6个月不良结局独立相关(ln(NT-proBNP)校正OR 2.495,95%CI 1.648-3.776,p<0.001)。
  • 不良结局率随RCR三分位升高而上升:第一分位21.4%、第二分位47.9%、第三分位63.8%(p<0.001)。
  • 将RCR和NT-proBNP加入IMPACT模型后区分度改善(AUC 0.924 vs. 0.874;p<0.001)。

适用人群与场景

  • 连续收治于苏州大学附属第一医院创伤中心与神经外科的中重度TBI患者,共210例,收治时间为2023年1月至2025年1月。

研究设计与关键结果

  • 研究类型:回顾性分析;样本量:210例连续患者;人群:中重度TBI;主要终点:6个月不良结局(Glasgow结局量表评分<4)。
  • 较高RCR与不良结局独立相关(校正OR 4.871,95%CI 1.929-12.300,p<0.001);较高ln(NT-proBNP)与不良结局独立相关(校正OR 2.495,95%CI 1.648-3.776,p<0.001)。
  • 不良结局率随RCR三分位升高而上升:第一分位21.4%、第二分位47.9%、第三分位63.8%(p<0.001)。
  • 将RCR和NT-proBNP加入IMPACT模型后区分度改善(AUC 0.924 vs. 0.874;p<0.001)。

证据类型、等级与局限

  • 证据类型:回顾性分析;局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为联合评估RCR和NT-proBNP可提高中重度TBI的早期预后准确性,支持其作为可及生物标志物用于细化风险分层和个体化管理。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Traumatic brain injury (TBI) is recognized as a significant global public health issue associated with high morbidity and mortality. This study aimed to overcome the limitations of traditional prognostic models (e.g., International Mission on Prognosis and Analysis of Clinical Trials, IMPACT) by evaluating the red cell distribution width-to-serum calcium ratio (RCR) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) to determine their prognostic value among patients with moderate-to-severe TBI.

METHODS: We retrospectively analyzed 210 consecutive patients admitted to the Trauma Center and Department of Neurosurgery, First Affiliated Hospital of Soochow University (January 2023-January 2025). Demographic, clinical, laboratory, and radiological data were collected. The primary endpoint was 6‑month unfavorable outcome (Glasgow Outcome scale score < 4). Associations between biomarkers and outcome were estimated using multivariable logistic regression. Nonlinearity was examined with restricted cubic splines. Discrimination was compared using receiver operating characteristic curves.

RESULTS: Higher RCR and NT‑proBNP were independently associated with unfavorable outcome [adjusted OR for RCR, 4.871; 95% CI 1.929-12.300; adjusted OR for ln(NT‑proBNP), 2.495; 95% CI 1.648-3.776; both p < 0.001]. Rates of unfavorable outcome rose across RCR tertiles (21.4%, 47.9%, and 63.8%; p < 0.001). Adding both biomarkers to the IMPACT model improved discrimination (AUC 0.924 vs. 0.874; p < 0.001).

CONCLUSIONS: Combined assessment of RCR and NT-proBNP enhances early prognostic accuracy in moderate-to-severe TBI, supporting their potential role as accessible biomarkers for refined risk stratification and individualized management.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Liu L, Wu C, Wang X, et al. Development and Validation of a Prognostic Model Integrating the Red Cell Distribution Width-to-Serum Calcium Ratio and N-terminal pro-B-type Natriuretic Peptide for Outcome Prediction after Moderate-to-Severe Traumatic Brain Injury. Neurocrit Care. 2026. PMID: 41709068. doi:10.1007/s12028-026-02451-0

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。